Detecting somatic mutations within epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) driver gene status has become a diagnostic routine for lung adenocarcinoma [4–6]. The gene discussed is EGFR; the disease is lung adenocarcinoma.